Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311)

por Chawla, Sant P., Tellez, Walter Andree, Chomoyan, Hripsime, Valencia, Chrysler, Ahari, Amir, Omelchenko, Nadezhda, Makrievski, Stefan, Brigham, Don A., Chua-Alcala, Victoria, Quon, Doris, Moradkhani, Ania, Gordon, Erlinda M.
Publicado 2023

SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma

por Gordon, Erlinda Maria, Chawla, Sant P., Tellez, Walter Andree, Younesi, Elan, Thomas, Sonu, Chua-Alcala, Victoria S., Chomoyan, Hripsime, Valencia, Chrysler, Brigham, Don Arlen, Moradkhani, Ania, Quon, Doris, Srikureja, Amornchit, Wong, Steven G., Tseng, William, Federman, Noah
Publicado 2023